Basic Information
| RNALocate ID: | RLID:11001859 |
| RNA Symbol: | hsa-miR-125a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-125a |
| RNA ID: | miRBase:MIMAT0000443 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21670082 |
| Tissue/Cell Line: | Renal cancer cells |
| Method: | qRT-PCR|TaqMan miRNA assay |
| Condition: | Human CD105+ and CD105- renal carcinomas cells |
| Description: | Exosomal miRNAs as potential biomarkers and therapeutic targets. Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001809 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001810 | Mitochondrion | Myotube | 27396686 |
| RLID:01001811 | Mitochondrion | Skeletal muscle cells | 27563705 |
| RLID:01001812 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001813 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001814 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001815 | Nucleolus | HeLa cells | 23940654 |
| RLID:01001816 | Nucleolus | Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001858 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001860 | Exosome | Breast milk | 22211110 |
| RLID:11001861 | Exosome | Brain tissue | 23382797 |
| RLID:11001862 | Exosome | Plasma | 23663360 |
| RLID:11001863 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001864 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001865 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001866 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11001867 | Microvesicle | Hepatoma cells | 23771658 |
| RLID:11001868 | Microvesicle | Serum | 24797360 |
| RLID-D:11000091 | Exosome | Blood|Breast milk|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000371 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-125a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-07005 |
| MNDR | hsa-miR-125a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-07006 |
| MNDR | hsa-miR-125a-5p | Oral squamous cell carcinoma | MNDR-E-MI-07007 |
| MNDR | hsa-miR-125a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-07008 |
| MNDR | hsa-miR-125a-5p | Medulloblastoma | MNDR-E-MI-07009 |
| MNDR | hsa-miR-125a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-07010 |
| MNDR | hsa-miR-125a-5p | Lymphoma | MNDR-E-MI-07011 |
| MNDR | hsa-miR-125a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-07012 |
| MNDR | hsa-miR-125a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-07013 |
| MNDR | hsa-miR-125a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-07014 |
| MNDR | hsa-miR-125a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-07015 |
| MNDR | hsa-miR-125a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-07016 |
| MNDR | hsa-miR-125a-5p | Breast cancer luminal | MNDR-E-MI-07017 |
| MNDR | hsa-miR-125a-5p | Anencephaly | MNDR-E-MI-07018 |
| MNDR | hsa-miR-125a-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-07019 |
| MNDR | hsa-miR-125a-5p | Prostate cancer | MNDR-E-MI-07020 |
| MNDR | hsa-miR-125a-5p | Prostate carcinoma | MNDR-E-MI-07021 |
| MNDR | hsa-miR-125a-5p | Gastric cancer | MNDR-E-MI-07022 |
| MNDR | hsa-miR-125a-5p | Alzheimer disease | MNDR-E-MI-07023 |
| MNDR | hsa-miR-125a-5p | Intracranial aneurysm | MNDR-E-MI-07024 |
| MNDR | hsa-miR-125a-5p | Esophageal carcinoma | MNDR-E-MI-07025 |
| MNDR | hsa-miR-125a-5p | Dysautonomia familial | MNDR-E-MI-07026 |
| MNDR | hsa-miR-125a-5p | Leukemia | MNDR-E-MI-07027 |
| MNDR | hsa-miR-125a-5p | Acute leukemia | MNDR-E-MI-07028 |
| MNDR | hsa-miR-125a-5p | Cardiovascular disease | MNDR-E-MI-07029 |
| MNDR | hsa-miR-125a-5p | Lung cancer | MNDR-E-MI-07030 |
| MNDR | hsa-miR-125a-5p | Parkinson disease | MNDR-E-MI-07031 |
| MNDR | hsa-miR-125a-5p | Basal-like breast cancer | MNDR-E-MI-07032 |
| MNDR | hsa-miR-125a-5p | Vascular diseases | MNDR-E-MI-07033 |
| MNDR | hsa-miR-125a-5p | Thyroid cancer | MNDR-E-MI-07034 |
| MNDR | hsa-miR-125a-5p | Pancreatic cancer | MNDR-E-MI-07035 |
| MNDR | hsa-miR-125a-5p | Malignant melanoma | MNDR-E-MI-07036 |
| MNDR | hsa-miR-125a-5p | Rectum adenocarcinoma | MNDR-E-MI-07037 |
| MNDR | hsa-miR-125a-5p | Colon cancer | MNDR-E-MI-07038 |
| MNDR | hsa-miR-125a-5p | Colon adenocarcinoma | MNDR-E-MI-07039 |
| MNDR | hsa-miR-125a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-07040 |
| MNDR | hsa-miR-125a-5p | Ovarian cancer | MNDR-E-MI-07041 |
| MNDR | hsa-miR-125a-5p | Basal cell carcinoma | MNDR-E-MI-07042 |
| MNDR | hsa-miR-125a-5p | Prostate adenocarcinoma | MNDR-E-MI-07043 |
| MNDR | hsa-miR-125a-5p | Carcinoma ductal breast | MNDR-E-MI-07044 |
| MNDR | hsa-miR-125a-5p | Glioblastoma | MNDR-E-MI-07045 |
| MNDR | hsa-miR-125a-5p | Astrocytoma | MNDR-E-MI-07046 |
| MNDR | hsa-miR-125a-5p | Glioma | MNDR-E-MI-07047 |
| MNDR | hsa-miR-125a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-07048 |
| MNDR | hsa-miR-125a-5p | Chordoma | MNDR-E-MI-07049 |
| MNDR | hsa-miR-125a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-07050 |
| MNDR | hsa-miR-125a-5p | Osteosarcoma | MNDR-E-MI-07051 |
| MNDR | hsa-miR-125a-5p | Carotid artery thrombosis | MNDR-E-MI-07052 |
| MNDR | hsa-miR-125a-5p | Inclusion body myositis | MNDR-E-MI-07053 |
| MNDR | hsa-miR-125a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-07054 |
| MNDR | hsa-miR-125a-5p | Meningioma | MNDR-E-MI-07055 |
| MNDR | hsa-miR-125a-5p | Uterine cancer | MNDR-E-MI-07056 |
| MNDR | hsa-miR-125a-5p | Cervical adenocarcinoma | MNDR-E-MI-07057 |
| MNDR | hsa-miR-125a-5p | Gastric adenocarcinoma | MNDR-E-MI-07058 |
| MNDR | hsa-miR-125a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-07059 |
| MNDR | hsa-miR-125a-5p | Lung squamous cell carcinoma | MNDR-E-MI-07060 |
| MNDR | hsa-miR-125a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-07061 |
| MNDR | hsa-miR-125a-5p | Lung adenocarcinoma | MNDR-E-MI-07062 |
| MNDR | hsa-miR-125a-5p | Adrenocortical cancer | MNDR-E-MI-07063 |
| MNDR | hsa-miR-125a-5p | Thyroid carcinoma | MNDR-E-MI-07064 |
| MNDR | hsa-miR-125a-5p | Bladder urothelial carcinoma | MNDR-E-MI-07065 |
| MNDR | hsa-miR-125a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-07066 |
| MNDR | hsa-miR-125a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-07067 |
| MNDR | hsa-miR-125a-5p | Carcinoma renal cell | MNDR-E-MI-07068 |
| MNDR | hsa-miR-125a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-07069 |
| MNDR | hsa-miR-125a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-07070 |
| MNDR | hsa-miR-125a-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-07071 |
| MNDR | hsa-miR-125a-5p | Cholangiocarcinoma | MNDR-E-MI-07072 |
| MNDR | hsa-miR-125a-5p | Thyroid gland disease | MNDR-E-MI-07073 |
| MNDR | hsa-miR-125a-5p | Esophageal cancer | MNDR-E-MI-07074 |
| MNDR | hsa-miR-125a-5p | Liver cirrhosis | MNDR-E-MI-07075 |
| MNDR | hsa-miR-125a-5p | Encephalopathy bovine spongiform | MNDR-E-MI-07076 |
| MNDR | hsa-miR-125a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-07077 |
| MNDR | hsa-miR-125a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-07078 |
| MNDR | hsa-miR-125a-5p | Acute t cell leukemia | MNDR-E-MI-07079 |
| MNDR | hsa-miR-125a-5p | Fibromyalgia | MNDR-E-MI-07080 |
| MNDR | hsa-miR-125a-5p | Breast invasive carcinoma | MNDR-E-MI-07081 |
| MNDR | hsa-miR-125a-5p | Cerebrovascular disease | MNDR-E-MI-07082 |
| MNDR | hsa-miR-125a-5p | Juvenile rheumatoid arthritis | MNDR-E-MI-07083 |
| MNDR | hsa-miR-125a-5p | Hepatocellular carcinoma | MNDR-E-MI-07084 |
| MNDR | hsa-miR-125a-5p | Rheumatoid arthritis | MNDR-E-MI-07085 |
| MNDR | hsa-miR-125a-5p | Malignant pleural mesothelioma | MNDR-E-MI-07086 |
| MNDR | hsa-miR-125a-5p | Retinoblastoma | MNDR-E-MI-07087 |
| MNDR | hsa-miR-125a-5p | Neuroblastoma | MNDR-E-MI-07088 |
| MNDR | hsa-miR-125a-5p | Barrett's adenocarcinoma | MNDR-E-MI-07089 |
| MNDR | hsa-miR-125a-5p | Hodgkin lymphoma | MNDR-E-MI-07090 |
| MNDR | hsa-miR-125a-5p | Crohn disease | MNDR-E-MI-07091 |
| MNDR | hsa-miR-125a-5p | Tonsil cancer | MNDR-E-MI-07092 |
| MNDR | hsa-miR-125a-5p | Systemic lupus erythematosus | MNDR-E-MI-07093 |
| MNDR | hsa-miR-125a-5p | Acute myeloid leukemia | MNDR-E-MI-07094 |
| MNDR | hsa-miR-125a-5p | Colorectal cancer | MNDR-E-MI-07095 |
| MNDR | hsa-miR-125a-5p | Nasopharynx carcinoma | MNDR-E-MI-07096 |
| MNDR | hsa-miR-125a-5p | Type 2 diabetes mellitus | MNDR-E-MI-07097 |
| MNDR | hsa-miR-125a-5p | Multiple myeloma | MNDR-E-MI-07098 |
| MNDR | hsa-miR-125a-5p | Recurrent pregnancy loss | MNDR-E-MI-07099 |
| MNDR | hsa-miR-125a-5p | Ovarian epithelial cancer | MNDR-E-MI-07100 |
| MNDR | hsa-miR-125a-5p | Ependymoma | MNDR-E-MI-07101 |
| MNDR | hsa-miR-125a-5p | Nasopharyngeal cancer | MNDR-E-MI-07102 |
| MNDR | hsa-miR-125a-5p | Sleep deprivation | MNDR-E-MI-07103 |
| MNDR | hsa-miR-125a-5p | Wounds and injuries | MNDR-E-MI-07104 |
| MNDR | hsa-miR-125a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-07105 |
| MNDR | hsa-miR-125a-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-07106 |
| MNDR | hsa-miR-125a-5p | Pancreatitis chronic | MNDR-E-MI-07107 |
| MNDR | hsa-miR-125a-5p | Stroke lacunar | MNDR-E-MI-07108 |
| MNDR | hsa-miR-125a-5p | Barrett's carcinogenesis | MNDR-E-MI-07109 |
| MNDR | hsa-miR-125a-5p | Duke C | MNDR-E-MI-07110 |
| MNDR | hsa-miR-125a-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-07111 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABL2 | Homo sapiens | RR00027148 |
TOP